Invention Grant
- Patent Title: Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
-
Application No.: US16986613Application Date: 2020-08-06
-
Publication No.: US10941201B2Publication Date: 2021-03-09
- Inventor: Tibor Keler , Joel Goldstein , Laura A. Vitale , Lizhen He , Tom O'Neill , Andrea Crocker , Karuna Sundarapandiyan , Lawrence J. Thomas , Jenifer Widger
- Applicant: Celldex Therapeutics, Inc.
- Applicant Address: US NJ Hampton
- Assignee: Celldex Therapeutics, Inc.
- Current Assignee: Celldex Therapeutics, Inc.
- Current Assignee Address: US NJ Hampton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Jeanne M. DiGiorgio, Esq.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07K14/54 ; C07K14/715 ; C07K14/705 ; A61K39/00
Abstract:
Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Public/Granted literature
- US20200369768A1 AGONISTIC ANTIBODIES THAT BIND HUMAN CD40 AND USES THEREOF Public/Granted day:2020-11-26
Information query
